Figure - available via license: Creative Commons Attribution 4.0 International
Content may be subject to copyright.
Source publication
Cancer prognosis is often based on a set of omics covariates and a set of established clinical covariates such as age and tumor stage. Combining these two sets poses challenges. First, dimension difference: clinical covariates should be favored because they are low-dimensional and usually have stronger prognostic ability than high-dimensional omics...
